BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30111434)

  • 1. [Research Progress on Diagnosis and Treatment of B Cell Chronic Lymphoproliferative Disease--Review].
    Li YY; Hu DZ; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1220-1224. PubMed ID: 30111434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
    Li W; Fang P; Fu G; Liang H; Peng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical Features and Outcomes of the Patients with B-Cell Chronic Lymphoproliferative Disease in the New Drug Era].
    Xu CB; Hu M; Shen JZ; Xu HQ; Zheng RJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):722-729. PubMed ID: 37356932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
    Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S35-41. PubMed ID: 20568273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.
    Miao Y; Cao L; Sun Q; Li XT; Wang Y; Qiao C; Wang L; Wang R; Qiu HR; Xu W; Li JY; Wu YJ; Fan L
    Hematol Oncol; 2018 Feb; 36(1):121-127. PubMed ID: 28752619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.
    Costa ES; Pedreira CE; Barrena S; Lecrevisse Q; Flores J; Quijano S; Almeida J; del Carmen García-Macias M; Bottcher S; Van Dongen JJ; Orfao A
    Leukemia; 2010 Nov; 24(11):1927-33. PubMed ID: 20844562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.
    Lin P; Bueso-Ramos C; Wilson CS; Mansoor A; Medeiros LJ
    Am J Surg Pathol; 2003 Aug; 27(8):1104-13. PubMed ID: 12883242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept.
    Lin P; Medeiros LJ
    Adv Anat Pathol; 2005 Sep; 12(5):246-55. PubMed ID: 16210920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
    Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
    Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients.
    Quijano S; López A; Rasillo A; Barrena S; Luz Sánchez M; Flores J; Fernández C; Sayagués JM; Osuna CS; Fernández N; González M; Giraldo P; Giralt M; Pérez MC; Martin-Antoran JM; Gutiérrez O; Perdiguer L; Díaz Mediavilla J; González Silva M; Asensio Del Rio A; Cerveró C; Guerra JL; Butrón R; García Mdel C; Almeida J; Orfao A
    Blood; 2008 May; 111(10):5130-41. PubMed ID: 18337555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
    Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
    Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphoplasmacytic lymphoma with Waldenström's macroglobulinemia: a clinicopathological and immunophenotypic study of 40 Chinese patients].
    Liang DN; Li GD; Dai L; Huang J; Wang WY; Feng WH; Li FY; Liao DY
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):728-32. PubMed ID: 20079010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress on epigenetics of small B-cell lymphoma.
    Ruan X; Zhang R; Zhu H; Ye C; Wang Z; Dong E; Li R; Cheng Z; Peng H
    Clin Transl Oncol; 2022 Aug; 24(8):1501-1514. PubMed ID: 35334078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases.
    Yan Y; Lv R; Xiong W; Li Z; Wang Y; Yu Y; Yu Z; Wang T; Sui W; Liu W; Zou D; Yi S; Qiu L
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):e270-e283. PubMed ID: 32220598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma.
    van der Velden VH; Hoogeveen PG; de Ridder D; Schindler-van der Struijk M; van Zelm MC; Sanders M; Karsch D; Beverloo HB; Lam K; Orfao A; Lugtenburg PJ; Böttcher S; van Dongen JJ; Langerak AW; Kappers-Klunne M; van Lom K
    Blood; 2014 Jul; 124(3):412-9. PubMed ID: 24891323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.